Published in Stroke on February 01, 2001
Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry (2005) 1.21
Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper. Qual Health Care (2001) 1.16
European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. Eur J Prev Cardiol (2015) 0.99
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc (2013) 0.88
A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin. Int Arch Med (2013) 0.86
Stroke risk in AF: do AF patterns matter? Eur Heart J (2010) 0.84
Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology (2014) 0.83
Genetic Risk Prediction of Atrial Fibrillation. Circulation (2016) 0.83
Stroke Prevention in Atrial Fibrillation: Where are We Now? Clin Med Insights Cardiol (2012) 0.82
Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach. Aging Dis (2012) 0.82
Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly. Circulation (2015) 0.81
Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection. Clin Res Cardiol (2013) 0.81
A Review of the LARIAT Suture Delivery Device for Left Atrial Appendage Closure. J Tehran Heart Cent (2015) 0.79
An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol. BMC Cardiovasc Disord (2013) 0.78
Atrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patients. Ther Clin Risk Manag (2016) 0.78
Atrial Fibrillation Identified During Echocardiography in a Patient with Recurrent Cardioembolic Events: A Case Report. Am J Case Rep (2016) 0.77
Atrial fibrillation in patients with ischemic stroke: A population-based study. Clin Epidemiol (2009) 0.77
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation. Vasc Health Risk Manag (2015) 0.77
Long-Term Outcomes after Stroke in Elderly Patients with Atrial Fibrillation: A Hospital-Based Follow-Up Study in China. Front Aging Neurosci (2016) 0.77
Treatment patterns associated with stroke prevention in patients with atrial fibrillation in three major cities in the People's Republic of china. Int J Gen Med (2013) 0.77
Is isolated aphasia associated with atrial fibrillation? A prospective study. Cerebrovasc Dis Extra (2014) 0.77
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure. Heart Fail Rev (2013) 0.77
Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial. BMC Fam Pract (2017) 0.75
Atrial high-rate episodes and stroke prevention. Europace (2017) 0.75
Left atrial appendage occlusion: A better alternative to anticoagulation? World J Cardiol (2017) 0.75
Stroke with atrial fibrillation or atrial flutter: a descriptive population-based study from the Brest stroke registry. BMC Geriatr (2015) 0.75
Stroke detection and prevention in atrial fibrillation. Br J Gen Pract (2015) 0.75
State Of The Art In Left Atrial Appendage Ligation - The Lariat. J Atr Fibrillation (2014) 0.75
Early consciousness disorder in acute ischemic stroke: incidence, risk factors and outcome. BMC Neurol (2016) 0.75
Cardiac Plug I and Amulet Devices: Left Atrial Appendage Closure for Stroke Prophylaxis in Atrial Fibrillation. J Atr Fibrillation (2015) 0.75
Clinical and Economic Implications of AF Related Stroke. J Atr Fibrillation (2016) 0.75
Atrial Fibrillation In Heart Failure: New Directions In Diagnosis, Risk Assessment And Risk Reduction. J Atr Fibrillation (2014) 0.75
Cardiac function and outcome in patients with cardio-embolic stroke. PLoS One (2014) 0.75
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility. Med Devices (Auckl) (2016) 0.75
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis (2016) 0.75
Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China. Front Neurol (2017) 0.75
Effect of age on long-term outcomes after stroke with atrial fibrillation: a hospital-based follow-up study in China. Oncotarget (2017) 0.75
Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial. Trials (2017) 0.75
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ (1999) 3.12
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. Nucleic Acids Res (1988) 2.32
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology (2007) 2.25
Epidemiology of distal symmetrical neuropathies in the Italian elderly. Neurology (2007) 1.94
Use of the CRIB (clinical risk index for babies) score in prediction of neonatal mortality and morbidity. Arch Dis Child Fetal Neonatal Ed (1995) 1.92
Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology (2000) 1.73
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology (1999) 1.64
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol (2009) 1.64
Variations in the management and survival of women under 50 years with breast cancer in the South East Thames region. Br J Cancer (1996) 1.63
FISH and cytogenetic characterization of a terminal chromosome 1q deletion: clinical case report and phenotypic implications. Am J Med Genet A (2003) 1.63
Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group. Stroke (1999) 1.56
Age-related white matter changes and cognitive impairment. Ann Neurol (2000) 1.52
A long-term follow-up of stroke patients. Stroke (1997) 1.50
The effect of 24 h blood pressure levels on early neurological recovery after stroke. J Intern Med (2001) 1.49
Estimates of the prevalence of acute stroke impairments and disability in a multiethnic population. Stroke (2001) 1.48
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol (1995) 1.46
Estimation of the incidence of stroke using a capture-recapture model including covariates. Int J Epidemiol (2001) 1.44
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
A new method for predicting recovery after stroke. Stroke (2001) 1.41
Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology (1993) 1.40
Does admission to hospital improve the outcome for stroke patients? Age Ageing (2001) 1.39
Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39
Babies' deaths linked to suboptimal care. BMJ (1995) 1.38
Randomised controlled trial to evaluate early discharge scheme for patients with stroke. BMJ (1997) 1.35
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc (2000) 1.30
White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 1.29
The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron (2001) 1.28
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke (2001) 1.27
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology (2007) 1.22
Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke (2000) 1.21
Transient global amnesia: a review emphasizing pathogenic aspects. Acta Neurol Scand (2000) 1.20
Consumers' views of the maternity services: implications for change and quality assurance. J Public Health Med (1991) 1.20
The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry (2005) 1.19
Three-month stroke outcome: the European Registers of Stroke (EROS) investigators. Neurology (2010) 1.18
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis (2008) 1.17
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology (2012) 1.17
Incidence of stroke in young adults in Florence, Italy. Stroke (1988) 1.16
Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health (2002) 1.13
Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea. J Pharmacol Exp Ther (2001) 1.13
Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol (2007) 1.12
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol (2001) 1.12
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol (2006) 1.10
Vascular risk factors and leuko-araiosis. Arch Neurol (1987) 1.09
Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (2000) 1.08
Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol (1987) 1.07
Economic consequences of early inpatient discharge to community-based rehabilitation for stroke in an inner-London teaching hospital. Stroke (1999) 1.07
Prevalence of CT-detected cerebral abnormalities in an elderly Swedish population sample. Acta Neurol Scand (2008) 1.07
Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: implications for direct CRH immunoassay. J Endocrinol (1995) 1.06
Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol (1998) 1.06
Cardiac troponin I and plasma D-dimer are related to proximal and bilateral extension of clots and right cardiac dysfunction in patients with pulmonary embolism. J Intern Med (2007) 1.05
Multilevel growth curve models with covariate effects: application to recovery after stroke. Stat Med (2001) 1.04
Thyroxine effect on intestinal Cl-/HCO3- exchange in hypo- and hyperthyroid rats. J Endocrinol (1996) 1.04
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program. Neurology (1994) 1.04
Clinical features, risk factors, and prognosis in transient global amnesia: a follow-up study. Eur J Neurol (2005) 1.03
Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab (1987) 1.03
Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology (2010) 1.03
Motor control in mirror movements: studies with transcranial magnetic stimulation. Suppl Clin Neurophysiol (2003) 1.02
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med (2009) 1.01
Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med (1998) 1.01
Variations in care and outcome in the first year after stroke: a Western and Central European perspective. J Neurol Neurosurg Psychiatry (2004) 1.01
Psychiatric disturbances in CADASIL: a brief review. Acta Neurol Scand (2008) 1.01
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol (1988) 1.01
Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke (1990) 1.00
Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol (1987) 1.00
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann N Y Acad Sci (2000) 1.00
Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology (1998) 1.00
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer (1998) 0.99
MRI and MR angiography of vertebral artery dissection. Neuroradiology (1997) 0.99
Fractal geometry in rat chimeras demonstrates that a repetitive cell division program may generate liver parenchyma. Dev Biol (1994) 0.98
Does patient satisfaction reflect differences in care received after stroke? Stroke (1999) 0.98
Calibration of the Periotron 8000 and 6000 by polynomial regression. J Periodontal Res (1999) 0.97
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol (2008) 0.97
Changes in Enzyme Levels During Germination of Seeds of Triticum durum. Plant Physiol (1968) 0.97
Is HIV testing in antenatal clinics worthwhile? Can we afford it? AIDS Care (1995) 0.97